{"id":252168,"date":"2026-09-17T13:10:43","date_gmt":"2026-09-17T07:40:43","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=252168"},"modified":"2026-09-17T13:10:44","modified_gmt":"2026-09-17T07:40:44","slug":"pfizer-bull-case-vs-bear-case-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pfizer-bull-case-vs-bear-case-2026\/","title":{"rendered":"Pfizer Share: Bull Case vs Bear Case for 2026"},"content":{"rendered":"
<\/div>\n
\n

Pfizer Key Stats (17 Sep 2026)<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Sector<\/td>\nPharmaceutical Formulations Manufacturing<\/td>\n<\/tr>\n
Current Market Price<\/td>\nRs 4,009.90<\/td>\n<\/tr>\n
52 Week High \/ Low<\/td>\nRs 5,578.50 \/ Rs 3,955.50<\/td>\n<\/tr>\n
Market Cap (Rs Cr)<\/td>\n18,360<\/td>\n<\/tr>\n
P\/E Ratio (Industry P\/E)<\/td>\n24.97 (50.28)<\/td>\n<\/tr>\n
Return on Equity<\/td>\n17.19%<\/td>\n<\/tr>\n
Debt to Equity<\/td>\n0.02<\/td>\n<\/tr>\n
EPS (TTM)<\/td>\nRs 160.70<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n1.87%<\/td>\n<\/tr>\n
Book Value<\/td>\nRs 918.71<\/td>\n<\/tr>\n
14 Day RSI<\/td>\nnot available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Quick Answer<\/strong><\/p>\n

The Pfizer bull case rests on extraordinarily deep discount to industry valuation, while the bear case points to sharp single session decline. At Rs 4,009.90, the stock sits between its 52 week low of Rs 3,955.50 and high of Rs 5,578.50, and both sides of the argument deserve a look before deciding. This article lays out the fundamentals and technical signals so you can weigh the Pfizer bull case against the risks yourself.<\/p>\n<\/div>\n

Pfizer<\/a> operates in the pharmaceutical formulations manufacturing space, and its shares currently trade at Rs 4,009.90, placing the stock within a 52 week range of Rs 3,955.50 to Rs 5,578.50. For anyone building or reviewing a position, the Pfizer bull case and the bear case both come down to the same underlying numbers read in different lights, and this piece walks through both sides using the company’s latest valuation, profitability, and technical readings.<\/p>\n

Rather than pushing you toward one conclusion, this Pfizer bull case analysis sets out what the bulls see in Pfizer shares and what the bears are watching, so you can match the picture against your own risk appetite and investment horizon. Understanding the Pfizer bull case thoroughly, alongside its counterpart, is essential before making any investment decision.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n